Latest News

BrainStorm Chief Medical Advisor Interviewed on Israel Radio Broadcast; States Stem Cell Therapy Treatment Ready For Clinical Trials

Geron Collaborators Publish Data on hESC-Derived Glial Progenitor Cell Therapy in Cervical Spinal Cord Injury

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders

Diamyd Technology Advances with US $ 1.84 Million Grant

Cerimon Pharmaceuticals Acquires European Rights to Topical Diclofenac Patch Cerimon Also Completes Enrollment of Phase 3 Diclofenac Patch Studies in Acute Pain Company Also Receives Notice of Allowance for Key US Patent Application

University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom

Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference

BIOLASE Introduces the Diolase 10(TM) Diode Laser for Pain Management, Therapeutic Applications

Retigabine Regulatory Update

More news... | RSS Feed...

Most Viewed

SRI International and F. Hoffmann-La Roche Launch Translational Medicine Collaboration to Study Methods and Treatments Associated with Cognitive Deficits across Neuropsychiatric Disorders

Cerimon Pharmaceuticals Acquires European Rights to Topical Diclofenac Patch Cerimon Also Completes Enrollment of Phase 3 Diclofenac Patch Studies in Acute Pain Company Also Receives Notice of...

Exelixis and Bristol-Myers Squibb Report New Phase 2 Data for XL184 in Patients With the Most Common and Aggressive Form of Brain Cancer

Novel agent for treatment of Parkinson's disease - Lu 02-750 - enters Lundbeck's development pipeline

ELEKTA'S RADIOSURGERY SOLUTIONS ON CENTER STAGE AT 2009 CONGRESS OF NEUROLOGICAL SURGEONS ANNUAL MEETING EXTEND RECEIVES FDA 510(K) CLEARANCE

Depomed, Inc. Announces Positive Top-Line Results from Phase 3 Clinical Trial of DM-1796 in Postherpetic Neuralgia

University of Cambridge and Life Technologies Collaborate on Landmark High Throughput Sequencing Hub in United Kingdom

Canadian authorities grant product approval for Intercell's Vaccine to prevent Japanese Encephalitis

Opexa Therapeutics Reports Third Quarter 2009 Financial Results and Corporate Update

Lundbeck starts clinical phase IIa with Lu AA24493 (cEPO) in Friedreich's ataxia in a study also assessing efficacy via biomarkers

Therapeutic Target

Cardiovascular

Dermatology

Endocrine and Metabolic

Gastroenterology

Genitourinary

Hematology

Immunology and Allergy

Infection

Musculoskeletal

Neurology

Obstetrics and Gynecology

Oncology

Ophthalmology

Psychiatry

Pulmonary

Categories

Deals and Alliances

Development

Financial Results

Financings

Intellectual Property

Regulatory

Press releases

Deals review

Headlines

PR Newswire